News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Jasna Hocevar-Trnka, MD, MPH

Articles by Jasna Hocevar-Trnka, MD, MPH

Experts share the results from the first-in-human phase 1 study of this treatment, plus a preview of its upcoming phase 2 trial.

RE104: A Novel, Fast-Acting Psychedelic for Postpartum Depression

ByRobert Alexander, MD,Jasna Hocevar-Trnka, MD, MPH,Nathan Bryson, PhD,Beatrix Taylor, BSc, MSc

June 26th 2024

Experts share the results from the first-in-human phase 1 study of this treatment, plus a preview of its upcoming phase 2 trial.

Latest Updated Articles

RE104: A Novel, Fast-Acting Psychedelic for Postpartum Depression
Published: June 26th 2024 | Updated:

Trending on Psychiatric Times

The Concept of Mental Illness, and Why the DSM Approach Is Wrong

Psychedelic PSX-001 for Generalized Anxiety Disorder: A Conversation With Lou Barbato, MD

Favorable Profile Data On MK-2214 for Treatment of Alzheimer Disease

What Happened to Psychopathology?

Psychiatry Wrapped 2025: Year in Review

© 2025 MJH Life Sciences^®

All rights reserved.